Ivaraiz 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively to glutamate-gated chloride ion channels in nerve and muscle cells of invertebrates, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and death of the parasite. It is effective against a broad spectrum of parasites including those causing onchocerciasis, strongyloidiasis, scabies, and other nematode infections. Ivaraiz 12 is indicated for the treatment of intestinal strongyloidiasis, onchocerciasis, and other susceptible parasitic infestations in adults and pediatric patients as prescribed. The tablet should be administered orally, with dosing tailored according to the specific infection and patient weight. Common side effects may include dizziness, nausea, diarrhea, and mild skin reactions; however, serious adverse effects are rare when used appropriately. Caution is advised in patients with hypersensitivity to ivermectin or in those with severe hepatic impairment. Ivaraiz 12 should be used under medical supervision, ensuring proper diagnosis and adherence to recommended dosing schedules to optimize therapeutic outcomes and minimize potential resistance development. It is contraindicated during pregnancy and lactation unless specifically advised by a healthcare professional.